A defend and destroy approach to curing HIV
A defend and destroy approach to curing HIV
批准号:
9254596
负责人:
David T Scadden
金额:
$228.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-01 至 2020-03-31
关键词:
AIDS/HIV problemAblationAdoptionAdvocateAllelesAmericanAnimalsAnti-Retroviral AgentsAntibodiesAreaAutologousAutologous TransplantationBerlinBiometryBloodCCR5 geneCD34 geneCD8-Positive T-LymphocytesCRISPR/Cas technologyCell CommunicationCellsClinicalClinical DataClinical TrialsClustered Regularly Interspaced Short Palindromic RepeatsComplexDevelopmentEffector CellEngineeringEngraftmentEuropeanGene-ModifiedGenesGeneticGoalsHIVHIV InfectionsHIV resistanceHIV-1Hematopoietic Stem Cell TransplantationHematopoietic stem cellsHomingHomologous TransplantationHumanImmune systemInfectionLaboratoriesLiverLymphopoiesisMapsMeasuresMessenger RNAMethodologyModificationMorbidity - disease rateMusMutationPatientsPharmaceutical PreparationsPharmacologyPreparationProceduresProtocols documentationResearch PersonnelResearch Project GrantsResistanceSafetyServicesStem cell transplantStem cellsSystemTechnologyTestingTherapeuticThymus GlandTimeToxic effectTransplantationViralViral reservoirauthoritybasecell typeclinical developmentcohortconditioningcostdesignexperiencefetalgene transplantation for gene therapygenetically modified cellsgenome editinghumanized mousein vivomeetingsmouse modelmultidisciplinarynovelnovel strategiespre-clinicalpreclinical developmentpublic health relevancestem cell nichesuccesssynergism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal seeks to achieve a durable cure of HIV through the use of autologous gene-modified cells in a 'Defend and Destroy' approach. Our central premise is that autologous cells can be used to eradicate HIV if they are 1. Genetically rendered HIV-uninfectable, and, 2. Enhanced in their activity by specific measures to destroy viral reservoirs. We have therefore assembled a team of investigators with complementary areas of expertise to execute the following specific aims: Specific aim 1: Utilize novel genetic modification technologies to engineer HIV- resistant immune systems with enhanced ability to destroy viral reservoirs. (Derrick Rossi, PI) This takes advantage of expertise in the Rossi lab with the CRISPR- Cas9 genome editing system and modified-mRNA technology. Specific aim 2: Enhance engraftment of gene modified hematopoietic stem cells with reduced toxicity, niche sparing conditioning of the host to minimize morbidity and costs without compromising targeting of viral reservoirs. (David Scadden, PI) Specific aim 3: Test approaches for viral control and vira reservoir depletion in a HIV-infected and anti-viral treated 'humanized' mouse model. (Todd Allen, PI) Specific aim 4: Pre-clinical development of HIV-resistant hematopoietic stem cells. (CRISPR Therapeutics, Rodger Novak, PI) Each aims maps to a project and the projects are supported by two cores: A. Administration and Biostatistics, and, B. Humanized mouse core generating, treating and analyzing BLT mice infected with HIV and treated with triple drug anti-retroviral therapy. Each of the four Specific Aims described above could be conducted independently as a scientifically significant research project. However, it is the synergy achieved
through the coordinated accomplishment of these aims that will enable the testing of a multi-pronged strategy for eradicating HIV infection. Testing of such a complex set of strategies, which together represent the platform for a "Defend and Destroy" approach to curing HIV infection, would simply not be possible if any one project were conducted out of the context of the other three. Thus, it is only the concerted execution of this package of four Projects, supported by two critical Cores, that will facilitate testing of the proposed, highly novel strateg for curing HIV.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional consequences of stem and progenitor cell heterogeneity
-
批准号:10413502
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2020
-
负责人:David T Scadden
-
依托单位:
Enhancing regeneration of stem cell-derived HIV-specific immune effectors
-
批准号:10163909
-
项目类别:
-
资助金额:$49.97万
-
财政年份:2020
-
负责人:David T Scadden
-
依托单位:
Enhancing regeneration of stem cell-derived HIV-specific immune effectors
-
批准号:10409803
-
项目类别:
-
资助金额:$55.27万
-
财政年份:2020
-
负责人:David T Scadden
-
依托单位:
Functional consequences of stem and progenitor cell heterogeneity
-
批准号:10188996
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2020
-
负责人:David T Scadden
-
依托单位:
Clonal tracking and molecular characterization of hematopoiesis under stress
-
批准号:10413504
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2020
-
负责人:David T Scadden
-
依托单位:
Enhancing regeneration of stem cell-derived HIV-specific immune effectors
-
批准号:10601073
-
项目类别:
-
资助金额:$58.87万
-
财政年份:2020
-
负责人:David T Scadden
-
依托单位:
Project 1: Implications of blood cell heterogeneity for CV disease
-
批准号:10238040
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2019
-
负责人:David T Scadden
-
依托单位:
Project 1: Implications of blood cell heterogeneity for CV disease
-
批准号:10469350
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2019
-
负责人:David T Scadden
-
依托单位:
Project 1: Implications of blood cell heterogeneity for CV disease
-
批准号:10670732
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2019
-
负责人:David T Scadden
-
依托单位:
Functional consequences of stem and progenitor cell heterogeneity
-
批准号:10641537
-
项目类别:
-
资助金额:$261.17万
-
财政年份:2017
-
负责人:David T Scadden
-
依托单位:
Administrative Core
-
批准号:10641538
-
项目类别:
-
资助金额:$2.58万
-
财政年份:2017
-
负责人:David T Scadden
-
依托单位:
Project 2 - Cell of origin contributions and vulnerabilities in clonal hematopoiesis
-
批准号:10641541
-
项目类别:
-
资助金额:$50.99万
-
财政年份:2017
-
负责人:David T Scadden
-
依托单位:
In vivo tracking of the hematopoietic stem cell clonal dynamics using a novel multi-fluorescent transgenic mouse model
-
批准号:9134179
-
项目类别:
-
资助金额:$23.95万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
Cell and Molecular Dynamics of Hematopoiesis In Vivo
-
批准号:9527128
-
项目类别:
-
资助金额:$73.96万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
CORE A: Administrative and Biostatisitcs Core
-
批准号:8897536
-
项目类别:
-
资助金额:$14.37万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
In vivo tracking of the hematopoietic stem cell clonal dynamics using a novel multi-fluorescent transgenic mouse model
-
批准号:8969345
-
项目类别:
-
资助金额:$19.97万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia
-
批准号:8866712
-
项目类别:
-
资助金额:$51.05万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
Cell and Molecular Dynamics of Hematopoiesis In Vivo
-
批准号:9312803
-
项目类别:
-
资助金额:$76.19万
-
财政年份:2015
-
负责人:David T Scadden
-
依托单位:
Mechanisms of Hematopoiesis in AIDS
-
批准号:8528891
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2012
-
负责人:David T Scadden
-
依托单位:
Bone Microenvironment Contributions to Metastatic Disease
-
批准号:8933402
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2011
-
负责人:David T Scadden
-
依托单位:
海外基金